The “MultiScopeX” proposal, submitted to the Danish Business Innovation Fund by the start-up company BioScopeX ApS, has been approved for funding. The MultiScopeX project involves eight Danish partners and will receive a grant of DKK 6 million.
The objective of MultiScopeX project is to develop a new tool for the diagnosis and prevention of certain types of cancer by using endoscopy. The innovative solution is based on the development of three main components which are integrated onto a prototype solution and subsequently tested through preclinical and clinical trials at Odense University Hospital and Rigshospitalet.
Ole Kjeldsen, CEO and Founder of BioScopeX, says that “The grant is a very important step in the further consolidation and development of BioScopeX. We are very pleased with the professional work Innovayt has done throughout the application process – They have provided a significant contribution to our success and we highly recommend Innovayt’s services”.